← All trials
NCT06192420
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 26, 2018
- Primary completion
- Nov 18, 2020
- Completion date
- Mar 25, 2021
- First posted
- Jan 5, 2024
- Last posted
- Jan 31, 2024
- Enrollment
- 809
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Biologische Heilmittel Heel GmbHLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.